Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA topological regulation by topoisomerase IIβ-DNA-PK interaction is important for controlled hypoxia-inducible gene expression. | bioRxiv | 2026 | 41993293 | PubTator, text mining | PubMed |
| Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction. | Int J Mol Sci | 2026 | 41977162 | PubTator, text mining | PubMed |
| PDS5A and TOP2B cooperate for chromatin recruitment via CTCF. | bioRxiv | 2026 | 41959374 | PubTator, text mining | PubMed |
| Cardioprotection in oncology: Mechanisms, risks and therapeutic strategies. | J Oncol Pharm Pract | 2026 | 41906425 | PubTator, text mining | PubMed |
| Exploring the Pleiotropic Cardioprotective Effects of GLP-1 Receptor Agonists in Preventing Anthracycline-Induced Cardiotoxicity: A Theoretical Proposal for Future Research. | Medicines (Basel) | 2026 | 41893369 | PubTator, text mining | PubMed |
| Topoisomerase I/II inhibitors: from established drugs to next-generation therapeutics. | Inflammopharmacology | 2026 | 41888388 | PubTator, text mining | PubMed |
| Aging is not a disease: an evolutionary and comparative biological reappraisal. | Biogerontology | 2026 | 41870707 | PubTator, text mining | PubMed |
| Enhancing cancer classification accuracy with a self-attention network using panel capture sequencing data. | Brief Bioinform | 2026 | 41870130 | PubTator, text mining | PubMed |
| Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicity in Cancer Survivors: From Bench to Bedside. | Drug Des Devel Ther | 2026 | 41810127 | PubTator, text mining | PubMed |
| Heart transplantation in pediatric oncology patients. | JHLT Open | 2026 | 41809976 | PubTator, text mining | PubMed |
| Physalin A interferes with cell cycle in human oral squamous carcinoma cells via DNA topoisomerase II/ATM/ATR/Chk signaling for G2/M phase arrest. | Arch Biochem Biophys | 2026 | 41796887 | PubTator, text mining | PubMed |
| Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity. | Int J Oncol | 2026 | 41789585 | PubTator, text mining | PubMed |
| Anthracyclines and the Heart: A Double-edged Sword With Therapeutic Hopes. | J Saudi Heart Assoc | 2026 | 41768301 | PubTator, text mining | PubMed |
| A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review. | Cancer Med | 2026 | 41766523 | PubTator, text mining | PubMed |
| Nanomedicine strategies for mitigating cancer therapy-related cardiovascular toxicity. | J Drug Target | 2026 | 41759001 | PubTator, text mining | PubMed |
| Quinoxaline Derivatives in Cancer Therapy: Insights into Mechanisms of Action and Therapeutic Applications. | Biomol Ther (Seoul) | 2026 | 41755772 | PubTator, text mining | PubMed |
| Mitochondria in the Crossfire: Cardiac Vulnerability During Chemotherapy. | Cancers (Basel) | 2026 | 41749927 | PubTator, text mining | PubMed |
| DNA topological regulation in RNA polymerase II transcription. | Cell Mol Biol Lett | 2026 | 41735852 | PubTator, text mining | PubMed |
| Heart failure induced by cancer therapies: focus on targeted agents, mechanisms, risk prediction, and clinical management. | Front Pharmacol | 2026 | 41727548 | PubTator, text mining | PubMed |
| Phosphatidylserine-Based Liposomes Encapsulating DMX-5804 Protect Against Doxorubicin-Induced Cardiotoxicity. | bioRxiv | 2026 | 41726889 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=2